Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 3Brain Neoplasms 3Medulloblastoma 2Glioblastoma 2Recurrence 1Gliosarcoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1

Interventions

Vincristine 8Magnetic Resonance Spectroscopy 8Cyclophosphamide 7Cisplatin 6X-Rays 5Specimen Handling 5Radiotherapy 5Phantoms, Imaging 5Irinotecan 5Carboplatin 5Temozolomide 4Radiation 4Platinum 4Nuclear Medicine Department, Hospital 4Lomustine 4palbociclib 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3ulixertinib 2tipifarnib 2tazemetostat 2sonidegib 2selpercatinib 2olaparib 2merphos 2larotrectinib 2ivosidenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Medulloblastoma × TPI-287 × Clear all
NCT00867568 2024-08-06

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Milton S. Hershey Medical Center

Phase 1 Completed
18 enrolled 12 charts
CNS

Medulloblastoma, Neuroblastoma, Recurrence

NCT01483820 2024-08-06

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Milton S. Hershey Medical Center

Phase 1/2 Terminated
8 enrolled 9 charts
CNS

Medulloblastoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡